PEOPLE - Lexington makes appointment:
This article was originally published in Clinica
Executive Summary
Lexington, Massachusetts-based molecular diagnostics company Predictive Biosciences has named Peter Klemm its first president and CEO. Dr Klemm was formerly CEO of molecular diagnostics company GeneOhm Sciences, which he built from its inception in 2002 and successfully sold to Becton Dickinson in 2006 for $230m. Prior to that, he was CEO of Jomed, a Swiss company that develops and manufactures products for interventional cardiology, radiology and minimally-invasive vascular surgery.